First Heartland Consultants’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-8
Closed -$5K 390
2023
Q3
$5K Hold
8
﹤0.01% 377
2023
Q2
$34.9K Hold
8
﹤0.01% 372
2023
Q1
$20.2K Hold
8
﹤0.01% 355
2022
Q4
$20.6K Hold
8
﹤0.01% 371
2022
Q3
$31 Hold
8
﹤0.01% 344
2022
Q2
$20K Hold
8
﹤0.01% 341
2022
Q1
$24K Buy
8
+4
+100% +$12K ﹤0.01% 347
2021
Q4
$23 Buy
4
+1
+33% +$6 ﹤0.01% 368
2021
Q3
$30K Hold
3
﹤0.01% 385
2021
Q2
$30K Buy
+3
New +$30K ﹤0.01% 381